Jump to navigation Jump to search
|Source||Humanized (from mouse)|
|Chemical and physical data|
|Molar mass||175130.42 g·mol−1|
This drug was developed by EMD Pharmaceuticals.
- Statement On A Nonproprietary Name Adopted By The Usan Council - Tucotuzumab Celmoleukin, American Medical Association.
- Clinical trial number NCT00016237 at ClinicalTrials.gov
- "Definition of tucotuzumab celmoleukin". National Cancer Institute.